ONTX News | Roxom Stocks

1 BTC

- USD

Loading market data...

AUM

N/A

Volume

5.90K

Yield

N/A

Chart Financials Earnings News About Insider Filings

Traws Pharma Announces New Employee Inducement GrantsNEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onconova Therapeutics, Inc. (the “Merger”).GlobeNewswire Inc. · Apr 2, 2024

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024GlobeNewswire Inc. · Mar 8, 2024

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketShares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Icosavax also reported topline interim Phase 2 results for combination VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults. Icosavax shares gained 44.8% to $15.19 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Bruush Oral Care Inc. (NASDAQ: BRSH) shares rose 76.8% to $0.2882 in pre-market trading after gaining over 5% on Monday. Connect Biopharma Holdings Limited (NASDAQ: CNTB) rose 32.2% to $1.19 in pre-market trading. Connect Biopharma will present top-line data from the global Phase 2b trial evaluating rademikibart’s efficacy and safety in patients with moderate-to-severe asthma on Dec. 12, 2023. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 28% to $0.3159 in pre-market trading. Kaival Brands recently appointed James W. Dobbins as General Counsel. IN8bio, Inc.(NASDAQ: INAB) gained ...Benzinga · Dec 12, 2023

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. bluebird bio shares rose 6.6% to $3.05 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 142.6% to $0.7399 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 79.4% to $0.7538 on continued volatility after the company last week received notification for not meeting the deadline to file its financial reports for several periods in 2023. Jet.AI Inc. (NASDAQ: JTAI) climbed 66% to $2.7550. The company recently posted a narrower quarterly loss. Assure Holdings Corp. (NASDAQ: IONM) gained 69.9% to $0.5950. Intchains Group Limited (NASDAQ: ICG) rose 25.8% to $11.02. Professional Diversity Network, Inc. (NASDAQ: IPDN) rose 23.3% to $2.64. Minim, Inc. (NASDAQ: MINM) gained 20% to $3.7450. MorphoSys AG (NASDAQ: MOR) rose 17.4% to $8.28 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting. The Cigna Group (NYSE: CI) shares gained 16.8% to $302.25. Cigna has withdrawn from its proposed merger with Humana Inc. (NYSE: HUM). Macy's, Inc. (NYSE: M) rose 16.4% to $20.24. An investor consortium has tabled a $5.8 billion bid to acquire Macy's, in an attempt to privatize the iconic department store chain. Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares rose 15.6% to $0.7421. Onconova Therapeutics' preclinical narazaciclib data at SABCS highlighted differentiated anti-tumor activity v. other CDK4/6i's. Dogness (International) Corporation ...Benzinga · Dec 11, 2023

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’sOnconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’sGlobeNewswire Inc. · Dec 8, 2023

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity ConferenceOnconova presenting at NobleCon19 Dec 4-5 in Boca Raton, FLGlobeNewswire Inc. · Nov 28, 2023

Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsGlobeNewswire Inc. · Nov 14, 2023

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023GlobeNewswire Inc. · Nov 7, 2023

Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCLPreclinical data indicate that narazaciclib shows monotherapy and combination anti-tumor activity in ibrutinib-sensitive and resistant cells and xenograft modelsGlobeNewswire Inc. · Nov 2, 2023

ONTXCorgi ONTO 2x Daily ETF

ONTX

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ONTX yet.

Related Tickers

Earnings

Volume

5.90K